CPT Awarded the Garfield Weston Foundation Grant

The Cure Parkinson’s Trust is delighted to receive a grant from the Garfield Weston Foundation this month! This funding will be put towards the sub-study currently being run alongside the Simvastatin trial. This sub-study will use our newly created Parkinson's Clinical Trials Charter (developed by Parkinson’s Movement) to help us learn what motivates patients to become involved in clinical trials and what barriers there might be to their participation.

We hope the results of this study will help us to design and deliver streamlined and effective Parkinson’s clinical trials which genuinely reflect the needs of the participants. Many thanks to the Garfield Weston Foundation for their generous support of this incredibly important project.

Latest

For some considerable time CPT has been interested in nerve growth factors or 'neurotrophic' factors for Parkinson's. GDNF, CDNF and C-CDNF are three interesting candidates and our research work within this field continues with drive and urgency.

Dr. Johnny Acheson is an Emergency Medical Consultant who is also living with Parkinson’s. Johnny has created sketches to fundraise and to educate about Parkinson’s and depict the humorous side of working in emergency medicine!

Over 50 cyclists, including Mike Tindall and Iain Balshaw, will set off independently on 28 June to tackle what would have been the toughest day on the 'Raid Alpine' ride - but instead, they'll be doing this around their local area!

Related

CPT's President Tom Isaacs has used his networking powers to help engage a stellar list of renowned contemporary artists to create individual pieces of work to raise funds for The Cure Parkinson's Trust.

Naga Munchetty and James Haggar hosted the Batchworth Golf Club Foxes Invitation Meeting. James is presiding over his year of captaincy at the club and The Cure Parkinson's Trust is delighted to be his chosen beneficiary charity.

Researchers at Johns Hopkins have two important new clues in the fight against Parkinson's: blocking an enzyme prevents the disease in mice and a chemical tag on a second protein may signal the disorder's presence.

A postmortem examination of a patient with Parkinson's who underwent dopaminergic cell transplantation 24 years ago has shown that the transplanted neurons had reinnervated the brain for all that time.

On Sunday 24th April, CPT's team of dedicated runners hit the streets of London in support of our research. We can't thank them enough for their mammoth efforts over these past months and, of course, that huge feat yesterday!

Most read

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

At this current time, we are working remotely and are unable to fulfill orders made via our online shop. We kindly ask that you refrain from purchasing items until normal working practices are resumed. Thank you for your patience. Please stay safe and well. From all at CPT.